LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
1,453,162
Share change
+1,422,781
Total reported value
$15,694,000
Price per share
$10.80
Number of holders
24
Value change
+$15,472,000
Number of buys
23
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q1 2014

As of 31 Mar 2014, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,453,162 shares. The largest 10 holders included Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, FMR LLC, Belmont Global Advisors, Inc., EAM Investors, LLC, Iguana Healthcare Management, LLC, Trellus Management Company, LLC, Russell Frank Co/, Spark Investment Management LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.